Results in mice have been promising (Image: Getty) A new drug has been shown to extend the lifespan of lab mice by a staggering 25 per cent, reveals a recent study. Excited researchers are now considering the "tantalising" possibility that these drugs could similarly benefit elderly humans. The team is optimistic that their discovery might one day help prolong healthy ageing in humans by diminishing frailty and other ageing indicators.
The treated mice enjoyed an average lifespan of 155 weeks, which was significantly longer than the 120 weeks observed in their untreated counterparts. The study highlighted that the drug notably decreased cancer-related deaths among the mice, alongside a reduction in diseases typically caused by chronic inflammation and metabolic issues, which are common signs of ageing. In essence, the mice not only lived longer but also healthier lives, with minimal adverse effects reported.
Scientists from the Medical Research Council Laboratory of Medical Science and Imperial College London have identified that deactivating a protein known as IL-11 can boost the healthy lifespan of mice. In humans, this protein's levels rise with age, and previous studies have associated it with various ageing-related conditions such as chronic inflammation, metabolic disorders, muscle deterioration and frailty, reports Gloucestershire Live . function loadOvpScript(){let el=document.
createElement('script');el.setAttribute('src','https://live.primis.
tech/live/liveView.php?s=.
